- cafead Nov 07, 2023 at 09:52: AM
via Gilead Sciences and Arcus Biosciences have reported initial assessment data from Arm A1 of the EDGE-Gastric clinical trial of domvanalimab in combination with zimberelimab and chemotherapy.
The international, multi-arm Phase II study is designed to assess the efficacy and safety of various combinations of domvanalimab and zimberelimab for treating upper gastrointestinal (GI) cancers.
article source
The international, multi-arm Phase II study is designed to assess the efficacy and safety of various combinations of domvanalimab and zimberelimab for treating upper gastrointestinal (GI) cancers.
article source